3/A

FORM 3/A SUBMISSION

Company: ARS Pharmaceuticals, Inc.
Filed: December 7, 2020
Period of Report: December 3, 2020
Accession Number: 0001209191-20-062011

View Document ↗ View on SEC.gov ↗